dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

Sound Imaging launches MR patient motion and detection system, SAMM MD Reduces repeat scans, prevents interruption to workflow

New MR methodology may distinguish benign and cancerous lymph nodes Could be used before surgery and help determine treatment

Gadolinium not required in 3T MR multiple sclerosis follow-up scans Longitude subtraction mapping just as sensitive: study

FDA gives thumbs-up to Genetesis MCG cardiac imaging system Measures magnetic fields produced by heart's electrical activity

BSWH to install Glassbeam's CLEAN blueprint to leverage machine uptime Will include integrated CMMS software by EQ2

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

Siemens focuses on digitalization at HIMSS Its expanded digital service portfolio will be on display

Making the 'virtual biopsy' a reality with MR spectroscopy

From the November 2018 issue of DOTmed HealthCare Business News magazine

By Dr. Alexander Lin

Magnetic resonance spectroscopy provides a “virtual biopsy” by measuring the concentrations of chemicals in the brain in a completely safe and noninvasive manner using standard MR equipment.
Changes in brain chemistry provide insight into pathophysiological changes that highly complement MR diagnoses.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



To date there are over 28,000 publications that detail the use of MR spectroscopy for a wide range of neurological disorders, however, this promising technique has not been fully utilized in clinical practice. Recent advances in technology are addressing these issues to translate MR spectroscopy from the benchtop to the bedside.

MR spectroscopy is ideally suited for repeated measurements and for measuring therapeutic outcomes by obtaining chemical signals, or metabolites, from a region of interest. A spectrum of peaks is generated whereby each peak is reflective of a chemical that resonates at a specific frequency (described in parts per million or ppm); the height of the peak reflects the concentration of that chemical in the brain (described as a ratio to creatine, institutional units, or millimolar concentration).

Brain metabolites
Different metabolites can be detected with MR spectroscopy and their biological roles can be used to provide pathophysiological insight for diagnosis and treatment monitoring.

The major metabolites include N-acetyl aspartate (NAA) which can be used to monitor neuronal health; choline (Cho), which indicates membrane turnover and can be used to assess tissue damage due to brain injury or cancer; measures of total creatine (Cr), which can be used as an energy marker although in most cases serves as an internal reference; myo-inositol (mI) is an osmolyte and astrocytic marker. More recently, MR spectroscopy has been shown to measure 2-hydroxyglutarate (2HG), an oncometabolite – a highly specific marker of cancer.

Glutamate (Glu, which is often indistinguishable from glutamine, they are frequently quantified jointly as Glx) is an excitatory neurotransmitter that is often modulated by disease and treatment; lactate (Lac), a marker of hypoxia; and glutathione (GSH), an anti-oxidant whose levels may reflect neuro-inflammation can be also measured but require specialized post-processing tools.

Clinical utilization
Different neurological disorders affect different brain metabolites differently. Every metabolite has a "normal" concentration that generates a pattern of peaks that is the same from person to person unless there is an underlying pathology. Diagnosis with MR spectroscopy can therefore be made by either comparing the numeric values of metabolite concentrations or by recognizing abnormal patterns of peaks in the spectra, such as in ECG interpretations.
  Pages: 1 - 2 - 3 >>

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED